- The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Otte, C., Jahn, H., Yassouridis, A., Arlt, J., Stober, N., Maass, P., Wiedemann, K., Kellner, M. Life Sci. (2003)